{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:45:03Z","timestamp":1790783103465,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301777\/2012-8"],"award-info":[{"award-number":["301777\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["FACEPE\/IBPG-1506-2.10\/18"],"award-info":[{"award-number":["FACEPE\/IBPG-1506-2.10\/18"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","award":["VPPCB-007-FIO-18-2-17"],"award-info":[{"award-number":["VPPCB-007-FIO-18-2-17"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.intimp.2020.106434","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T06:04:54Z","timestamp":1585289094000},"page":"106434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Neurobiological findings underlying depressive behavior in Parkinson\u2019s disease: A review"],"prefix":"10.1016","volume":"83","author":[{"given":"Ingrid Prata","family":"Mendon\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Duarte-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Jos\u00e9 Maia","family":"Chaves-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belmira Lara da Silveira","family":"Andrade da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Alves","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106434_b0005","first-page":"30","article-title":"Environmental, life-style, and physical precursors of clinical Parkinson\u2019s disease: Recent findings from the Honolulu-Asia Aging Study","volume":"250","author":"Abbott","year":"2003","journal-title":"J. Neurol. Suppl."},{"key":"10.1016\/j.intimp.2020.106434_b0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuro.2019.07.003","article-title":"Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-\u03baB and \u03b1-synuclein expressions in mice","volume":"74","author":"Alabi","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2020.106434_b0015","article-title":"Correlation between emotional-affective disorders and gut microbiota composition in patients with Parkinson\u2019s disease","author":"Alifirova","year":"2017","journal-title":"Ann. Russ. Acad. Med. Sci."},{"key":"10.1016\/j.intimp.2020.106434_b0020","doi-asserted-by":"crossref","first-page":"2690205","DOI":"10.1155\/2019\/2690205","article-title":"Assessment of the levels of level of biomarkers of bone matrix glycoproteins and inflammatory cytokines from Saudi Parkinson patients","volume":"2019","author":"Alrafiah","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2020.106434_b0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12035-013-8554-z","article-title":"Neurodegeneration in Parkinson\u2019s disease: Interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins","volume":"49","author":"Anderson","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0030","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","article-title":"Gut permeability and microbiota in Parkinson\u2019s disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways","volume":"22","author":"Anderson","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2020.106434_b0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/syn.20535","article-title":"Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson\u2019s disease via norepinephrine transporter","volume":"62","author":"Arai","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.intimp.2020.106434_b0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03033137","article-title":"Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease","volume":"5","author":"Asanuma","year":"2003","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0045","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.3390\/ijms20174256","article-title":"Omega-3 fatty acids and neurodegenerative diseases: new evidence in clinical trials","volume":"20","author":"Avallone","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2020.106434_b0050","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/ijms19113543","article-title":"Inhibition of microglia-derived oxidative stress by ciliary neurotrophic factor protects dopamine neurons in vivo from MPP+ neurotoxicity","volume":"19","author":"Baek","year":"2018","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2020.106434_b0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: Focus on Astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2020.106434_b0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2015.11.049","article-title":"Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson\u2019s disease and after chronic pramipexole treatment","volume":"314","author":"Berghauzen-Maciejewska","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2020.106434_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NRL.0b013e31823d7abb","article-title":"Nonmotor manifestations in parkinson disease","volume":"18","author":"Bernal-Pacheco","year":"2012","journal-title":"Neurologist"},{"key":"10.1016\/j.intimp.2020.106434_b0070","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.159.19.2349","article-title":"Effects of exercise training on older patients with major depression","volume":"159","author":"Blumenthal","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2020.106434_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.expneurol.2017.11.009","article-title":"Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson\u2019s disease in rats","volume":"300","author":"Bonato","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0080","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-007-9213-6","article-title":"Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0085","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.3233\/JPD-179001","article-title":"Neuropathological Staging of Brain Pathology in Sporadic Parkinson\u2019s disease: Separating the Wheat from the Chaff","volume":"7","author":"Braak","year":"2017","journal-title":"J. Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2020.106434_b0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/nu3050529","article-title":"Docosahexaenoic acid (DHA): An ancient nutrient for the modern human brain","volume":"3","author":"Bradbury","year":"2011","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2020.106434_b0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.plefa.2007.10.016","article-title":"The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition","volume":"77","author":"Brenna","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.intimp.2020.106434_b0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/154596839601000403","article-title":"Aerobic exercise and early parkinson\u2019s disease","volume":"10","author":"Bridgewater","year":"1996","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.intimp.2020.106434_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2015.00476","article-title":"Neuroinflammation and depression: Microglia activation, extracellular microvesicles and microRNA dysregulation","volume":"9","author":"Brites","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0115","first-page":"1","article-title":"Inflammatory bowel diseases and parkinson\u2019s disease","author":"Brudek","year":"2019","journal-title":"J. Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0120","series-title":"Advances in Applied Microbiology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.aambs.2015.02.001","article-title":"Microbiota regulation of the mammalian gut-brain axis","author":"Burokas","year":"2015"},{"key":"10.1016\/j.intimp.2020.106434_b0125","first-page":"661","article-title":"Parkinson \u2019 s disease : clinical review and update","volume":"32","author":"Cabreira","year":"2019","journal-title":"Acta Medica Cordoba."},{"key":"10.1016\/j.intimp.2020.106434_b0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/biom9080388","article-title":"A stage-based approach to therapy in Parkinson\u2019s disease","volume":"9","author":"Carrarini","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2020.106434_b0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1972.00490180022006","article-title":"Central monoamine metabolism in Parkinson\u2019s disease","volume":"27","author":"Chase","year":"1972","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2019.111975","article-title":"Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities","volume":"372","author":"Chaves-Filho","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.intimp.2020.106434_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0891988707301866","article-title":"Antidepressant treatment of veterans with Parkinson\u2019s disease and depression: Analysis of a national sample","volume":"20","author":"Chen","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0150","doi-asserted-by":"crossref","first-page":"00034","DOI":"10.3389\/fpsyt.2019.00034","article-title":"Systematic review of gut microbiota and major depression","volume":"10","author":"Cheung","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.intimp.2020.106434_b0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-510X(99)00198-7","article-title":"The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson\u2019s disease","volume":"172","author":"Choi","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2020.106434_b0160","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"B-amyloid stimulation of microglia anti monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.intimp.2020.106434_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: Relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.intimp.2020.106434_b0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2982.2010.01664.x","article-title":"The microbiome-gut-brain axis: From bowel to behavior","volume":"23","author":"Cryan","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.intimp.2020.106434_b0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-171296","article-title":"Targeting AMPK signaling as a neuroprotective strategy in Parkinson\u2019s disease","volume":"8","author":"Curry","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson\u2019s disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"da Silva","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0190","first-page":"5","article-title":"Effect of exercise on motor and nonmotor symptoms of Parkinson\u2019s disease","volume":"2015","author":"Dashtipour","year":"2015","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0195","doi-asserted-by":"crossref","first-page":"106351","DOI":"10.1016\/j.prostaglandins.2019.106351","article-title":"The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation","volume":"144","author":"de Bus","year":"2019","journal-title":"Prostagl. Other Lipid Mediat."},{"key":"10.1016\/j.intimp.2020.106434_b0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainresbull.2019.04.008","article-title":"Proconvulsant effects of sildenafil citrate on pilocarpine-induced seizures: Involvement of cholinergic, nitrergic and pro-oxidant mechanisms","volume":"149","author":"de Carvalho","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2020.106434_b0205","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: The Rotterdam Study","volume":"64","author":"De Lau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2020.106434_b0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does P.D pathology begin in the brain","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J. Neurop. Exp. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0215","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S1734-1140(13)71520-2","article-title":"Neuroendocrine link between stress, depression and diabetes","volume":"65","author":"Detka","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2020.106434_b0220","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial Activation and its Implications in the Brain Diseases","volume":"14","author":"Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"1\u201310","key":"10.1016\/j.intimp.2020.106434_b0225","first-page":"28698775","article-title":"Gut Feelings on Parkinson\u2019s and Depression","volume":"2017","author":"Dinan","year":"2017","journal-title":"Cerebrum"},{"key":"10.1016\/j.intimp.2020.106434_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2015.02.021","article-title":"Collective unconscious: How gut microbes shape human behavior","volume":"63","author":"Dinan","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0235","series-title":"Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside","article-title":"Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings","author":"Elsaid","year":"2019"},{"key":"10.1016\/j.intimp.2020.106434_b0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.intimp.2020.106434_b0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.05.052","article-title":"L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson\u2019s disease","volume":"218","author":"Eskow Jaunarajs","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2020.106434_b0250","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson\u2019s disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","article-title":"Are The Dorsal and Ventral Hippocampus functionally distinct structures?","volume":"65","author":"Fanselow","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2020.106434_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota-gut-brain signalling in Parkinson\u2019s disease: Implications for non-motor symptoms","volume":"27","author":"Felice","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00868","article-title":"The relevance of insulin action in the dopaminergic system","volume":"13","author":"Fiory","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0270","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1111\/ejn.14416","article-title":"Beyond drug-induced alteration of glutamate homeostasis, astrocytes may contribute to dopamine-dependent intrastriatal functional shifts that underlie the development of drug addiction: A working hypothesis","volume":"50","author":"Fouyssac","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson\u2019s disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: Importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2020.106434_b0285","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bpa.12137","article-title":"Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson\u2019s disease brain is region dependent","volume":"24","author":"Garcia-Esparcia","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.intimp.2020.106434_b0290","doi-asserted-by":"crossref","first-page":"P122","DOI":"10.1186\/1755-8166-7-S1-P122","article-title":"Role of Dopamine \u03b2 Hydroxylase (DBH) in Parkinson\u2019s disease patients of Indian population","volume":"7","author":"Ghosh","year":"2014","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.intimp.2020.106434_b0295","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and non-motor features of Parkinson\u2019s disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00894","article-title":"Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration","volume":"13","author":"Gonz\u00e1lez-Casacuberta","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0305","doi-asserted-by":"crossref","unstructured":"S. Grenham, G. Clarke, J.F. Cryan, T.G. Dinan, Brain-gut-microbe communication in health and disease, vol. 2, 2011, pp. 1\u201315. https:\/\/doi.org\/10.3389\/fphys.2011.00094.","DOI":"10.3389\/fphys.2011.00094"},{"key":"10.1016\/j.intimp.2020.106434_b0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2020.106434_b0315","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2020.106434_b0320","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","article-title":"Brain serotonin transporter binding in non-depressed patients with Parkinson\u2019s disease","volume":"14","author":"Guttman","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajmg.b.30136","article-title":"Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson\u2019s disease","volume":"133 B","author":"H\u00e5kansson","year":"2005","journal-title":"Am. J. Med. Genet. - Neuropsychiatr. Genet."},{"key":"10.1016\/j.intimp.2020.106434_b0330","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1600-0404.2001.00024.x","article-title":"Sleep disorders and depression in patients with Parkinson\u2019s disease","volume":"104","author":"Happe","year":"2001","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.intimp.2020.106434_b0335","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01244998","article-title":"Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis","volume":"93","author":"Hashiguti","year":"1993","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2020.106434_b0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2019.02.044","article-title":"Effects of chronic mild stress induced depression on synaptic plasticity in mouse hippocampus","volume":"365","author":"Hei","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.intimp.2020.106434_b0345","doi-asserted-by":"crossref","first-page":"16136","DOI":"10.1073\/pnas.1415191111","article-title":"Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress","volume":"111","author":"Hodes","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2020.106434_b0350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev-neuro-070815-014106","article-title":"Reward and Aversion","volume":"39","author":"Hu","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0355","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.35.4.565","article-title":"CSF dopamine-beta-hydroxylase activity in Parkinson\u2019s disease","volume":"35","author":"Hurst","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2020.106434_b0360","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2020.106434_b0365","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jnutbio.2018.02.004","article-title":"Low omega-6\/omega-3 ratio in a maternal protein-deficient diet promotes histone-3 changes in progeny neural cells and favors leukemia inhibitory factor gene transcription","volume":"55","author":"Isaac","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2020.106434_b0370","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.4049\/jimmunol.1301637","article-title":"Phenotypic polarization of activated astrocytes: the critical role of lipocalin-2 in the classical inflammatory activation of astrocytes","volume":"191","author":"Jang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106434_b0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.04.006","article-title":"Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease","volume":"155","author":"Joers","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0380","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF00565012","article-title":"5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson\u2019s syndrome treated with L-DOPA","volume":"3","author":"Johansson","year":"1971","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106434_b0385","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuro.2018.02.013","article-title":"Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson\u2019s disease","volume":"65","author":"Johnson","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2020.106434_b0390","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2006.03.059","article-title":"Reuptake of l-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters","volume":"402","author":"Kannari","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2020.106434_b0395","first-page":"143547","article-title":"Neurobiology of depression and anxiety in parkinson\u2019s disease","volume":"2011","author":"Kano","year":"2011","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","article-title":"Interleukin-1\u03b2 interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease","volume":"327","author":"Karpenko","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2020.106434_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.967","article-title":"Sleep disturbances and depression severity in patients with Parkinson\u2019s disease","volume":"8","author":"Kay","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.intimp.2020.106434_b0410","article-title":"Bacterial Metabolites Mirror Altered Gut 3 Microbiota Composition in Patients 4 with Parkinson\u2019s Disease","author":"Kessel","year":"2019","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0415","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2020.106434_b0420","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nn.4043","article-title":"Diversity of astrocyte functions and phenotypes in neural circuits","volume":"18","author":"Khakh","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00210-018-1466-8","article-title":"Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression","volume":"391","author":"Khedr","year":"2018","journal-title":"Naunyn. Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106434_b0430","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jns.2009.07.026","article-title":"Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment","volume":"287","author":"Kim","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2020.106434_b0435","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-\u03baB and interferon-\u03b2\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2020.106434_b0440","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: A sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0445","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s007020070078","article-title":"Genetic analysis of immunomodulating factors in sporadic Parkinson\u2019s disease","volume":"107","author":"Kr\u00fcger","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2020.106434_b0450","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(99)00238-7","article-title":"L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein","volume":"73","author":"Kuhn","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.intimp.2020.106434_b0455","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/mds.22246","article-title":"Prevalence and correlates of neuropsychiatric symptoms in Parkinson\u2019s disease without dementia","volume":"23","author":"Kulisevsky","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0460","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s12035-017-0529-z","article-title":"Prolonged dysfunction of astrocytes and activation of microglia accelerate degeneration of dopaminergic neurons in the rat substantia nigra and block compensation of early motor dysfunction induced by 6-OHDA","volume":"55","author":"Kuter","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0465","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","article-title":"Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson\u2019s Disease","volume":"43","author":"Lai","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0470","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson\u2019s disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0475","doi-asserted-by":"crossref","DOI":"10.1002\/mds.10387","article-title":"Higher Incidence of Depression Preceding the Onset of Parkinson\u2019s Disease: A Register Study","author":"Leentjens","year":"2003","journal-title":"Movement Disorders"},{"key":"10.1016\/j.intimp.2020.106434_b0480","doi-asserted-by":"crossref","first-page":"134297","DOI":"10.1016\/j.neulet.2019.134297","article-title":"Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson\u2019s disease","volume":"707","author":"Li","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2020.106434_b0485","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.106434_b0490","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","article-title":"Gut microbiota in patients with Parkinson\u2019s disease in southern China","volume":"53","author":"Lin","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0495","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease - Associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.intimp.2020.106434_b0500","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: Role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0505","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2015.03.031","article-title":"Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson\u2019s rats","volume":"95","author":"Liu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0510","first-page":"4411","article-title":"ER\u03b2-selective agonist alleviates inflammation in a multiple sclerosis model via regulation of MHC II in microglia","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0515","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainresbull.2014.11.006","article-title":"Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson\u2019s disease","volume":"110","author":"Luo","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2020.106434_b0520","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/17460441.2017.1362385","article-title":"Animal inflammation-based models of depression and their application to drug discovery","volume":"12","author":"Ma","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.intimp.2020.106434_b0525","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pharep.2018.11.005","article-title":"PPAR-\u03b3 agonist pioglitazone reduces microglial proliferation and NF-\u03baB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"71","author":"Machado","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2020.106434_b0530","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01250960","article-title":"The mechanism of perturbation in monoamine metabolism by L-DOPA therapy: in vivo and in vitro studies","volume":"90","author":"Maruyama","year":"1992","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2020.106434_b0535","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jmg.39.6.400","article-title":"Association of an interleukin 1b gene polymorphism (-511) with Parkinson\u2019s disease in Finnish patients","volume":"39","author":"Mattila","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.intimp.2020.106434_b0540","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI76304","article-title":"Gut\/brain axis and the microbiota Find the latest version : Gut\/brain axis and the microbiota","volume":"125","author":"Mayer","year":"2015","journal-title":"J. Clin. Investiog."},{"key":"10.1016\/j.intimp.2020.106434_b0545","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","article-title":"Altered serotonin metabolism in depressed patients with parkinson\u2019s disease","volume":"34","author":"Mayeux","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2020.106434_b0550","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1046\/j.1471-4159.1999.0732469.x","article-title":"Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic\/ventral mesencephalic co-cultures","volume":"73","author":"McNaught","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2020.106434_b0555","doi-asserted-by":"crossref","first-page":"107758","DOI":"10.1016\/j.neuropharm.2019.107758","article-title":"Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson\u2019s disease","volume":"160","author":"Mei","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0560","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/npp.2016.90","article-title":"Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience","volume":"42","author":"M\u00e9nard","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0565","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/0253-7176.155611","article-title":"Parkinson\u2019s disease, depression, and quality-of-life","volume":"37","author":"Menon","year":"2015","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.intimp.2020.106434_b0570","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.intimp.2020.106434_b0575","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2020.106434_b0580","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1139\/jpn.0709","article-title":"Imaging the serotonin transporter during major depressive disorder and antidepressant treatment","volume":"32","author":"Meyer","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0585","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.phymed.2012.04.002","article-title":"Effects of cannabinoids \u0394(9)-tetrahydrocannabinol, \u0394(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures","volume":"19","author":"Moldzio","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2020.106434_b0590","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/S1353-8020(11)70883-5","article-title":"3.210 Phytocannabinoids Tetrahydrocannabinol and Cannabidiol Act Against Rotenone Induced Damages in Murine Cell Cultures","volume":"18","author":"Moldzio","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0595","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization off motor, depressive-like and neurochemical alterations induced by y a short-term rotenone administration","volume":"64","author":"Moraes","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2020.106434_b0600","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00259-007-0651-7","article-title":"Quinolinic acid induced neurodegeneration in the striatum: A combined in vivo and in vitro analysis of receptor changes and microglia activation","volume":"35","author":"Moresco","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.intimp.2020.106434_b0605","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/1028415X.2017.1290928","article-title":"Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson\u2019s disease is mediated by a reduction of inducible nitric oxide synthase","volume":"21","author":"Mori","year":"2018","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0610","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: New perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2020.106434_b0615","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000849","article-title":"Allelic variation of serotonin transporter expression is associated with depression in Parkinson\u2019s disease","volume":"6","author":"M\u00f6ssner","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.intimp.2020.106434_b0620","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/bj2940343","article-title":"Interleukin-1 activates transcription factor NF\u03baB in glial cells","volume":"294","author":"Moynagh","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2020.106434_b0625","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jad.2019.04.088","article-title":"Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression","volume":"253","author":"M\u00fcller","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0630","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2017.09.020","article-title":"Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress","volume":"96","author":"Nasca","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2020.106434_b0635","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1523\/JNEUROSCI.5031-09.2010","article-title":"High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson\u2019s disease","volume":"30","author":"Navailles","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0640","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/glia.23467","article-title":"Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes","volume":"66","author":"Neal","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2020.106434_b0645","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: A systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.intimp.2020.106434_b0650","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/01616412.2016.1249997","article-title":"Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Pal","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0655","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9847696","article-title":"In sickness and in health: Perineuronal nets and synaptic plasticity in psychiatric disorders","volume":"2016","author":"Pantazopoulos","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.intimp.2020.106434_b0660","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresbull.2012.07.001","article-title":"Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress","volume":"89","author":"Park","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2020.106434_b0665","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3920\/BM2017.0202","article-title":"Gut bacterial composition in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Perez-Pardo","year":"2018","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.intimp.2020.106434_b0670","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with parkinson\u2019s disease","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2020.106434_b0675","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: State of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2020.106434_b0680","doi-asserted-by":"crossref","first-page":"4651031","DOI":"10.1155\/2019\/4651031","article-title":"Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus","volume":"2019","author":"Poggini","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.intimp.2020.106434_b0685","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","article-title":"Staging of serotonergic dysfunction in Parkinson\u2019s Disease: An in vivo 11C-DASB PET study","volume":"40","author":"Politis","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0690","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.baga.2014.03.004","article-title":"DHA effects in Parkinson disease depression","volume":"4","author":"Pomponi","year":"2014","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.intimp.2020.106434_b0695","first-page":"1","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of L-DOPA treatment","volume":"23","author":"Pylayeva-Gupta","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2020.106434_b0700","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","article-title":"Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease","volume":"70","author":"Qian","year":"2018","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.intimp.2020.106434_b0705","first-page":"1","article-title":"Parkinson\u2019s progression prediction using machine learning and serum cytokines","volume":"5","author":"Rastegar","year":"2019","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0710","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2020.106434_b0715","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2020.106434_b0720","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pneurobio.2015.04.003","article-title":"Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death","volume":"130","author":"Rossi","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0725","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0730","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2020.106434_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00574","article-title":"The Gut and Parkinson\u2019s Disease\u2014A Bidirectional Pathway","volume":"10","author":"Santos","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0740","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2006.05.030","article-title":"Quality of life and depression in Parkinson\u2019s disease","volume":"248","author":"Schrag","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2020.106434_b0745","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10571-006-9124-y","article-title":"Kynurenines impair energy metabolism in rat cerebral cortex","volume":"27","author":"Schuck","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0750","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","article-title":"Anxiety disorders and depressive disorders preceding Parkinson\u2019s disease: A case-control study","volume":"15","author":"Shiba","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0755","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000443890","article-title":"Prohedonic effect of cannabidiol in a rat model of depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.intimp.2020.106434_b0760","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.049","article-title":"Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats","volume":"622","author":"Silva","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2020.106434_b0765","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2020.106434_b0770","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/mds.27411","article-title":"Decreased noradrenaline transporter density in the motor cortex of Parkinson\u2019s disease patients","volume":"33","author":"Sommerauer","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2020.106434_b0775","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/j.1460-9568.2012.08200.x","article-title":"The habenula couples the dopaminergic and the serotonergic systems: Application to depression in Parkinson\u2019s disease","volume":"36","author":"Sourani","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0780","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","article-title":"L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells","volume":"67","author":"Stansley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0785","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0790","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.intimp.2020.106434_b0795","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpsychires.2014.10.003","article-title":"A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor","volume":"60","author":"Szuhany","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0800","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2011.01.006","article-title":"Serotonin-dependent depression in Parkinson\u2019s disease: A role for the subthalamic nucleus?","volume":"61","author":"Tan","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0805","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0810","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/glia.20204","article-title":"Neuroprotective role of astrocytes in cerebral ischemia: Focus on ischemic preconditioning","volume":"51","author":"Trendelenburg","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2020.106434_b0815","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2020.106434_b0820","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01243430","article-title":"Plasma Dopamine Beta Hydroxylase (D. B. H.) Activity in Parkinsonian Patients Under L-Dopa, and 2-Bromo-Alpha-Ergocriptine Loading","volume":"46","author":"Vardi","year":"1979","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2020.106434_b0825","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1176\/jnp.17.3.310","article-title":"Prevalence and treatment of depression in Parkinson\u2019s disease","volume":"17","author":"Veazey","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2015.01.014","article-title":"Limbic circuitry of the midline thalamus","volume":"54","author":"Vertes","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2020.106434_b0835","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.64.6.836","article-title":"Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease","volume":"64","author":"Wahner","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.intimp.2020.106434_b0840","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/13894501113149990208","article-title":"Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity","volume":"14","author":"Walker","year":"2013","journal-title":"Phenotype and Function. Curr. Drug Targets"},{"key":"10.1016\/j.intimp.2020.106434_b0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2020.106434_b0850","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2017.01.015","article-title":"Involvement of lateral habenula \u03b11 subunit-containing GABAA receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson\u2019s disease","volume":"116","author":"Wang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0855","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1532-5415.2004.52219.x","article-title":"Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson\u2019s Disease","volume":"52","author":"Weintraub","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.intimp.2020.106434_b0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu8020099","article-title":"Docosahexaenoic acid and cognition throughout the lifespan","volume":"8","author":"Weiser","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2020.106434_b0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00544","article-title":"Neuron-microglia interactions in mental health disorders: \u201cFor better, and for worse\u201d","volume":"7","author":"Wohleb","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.106434_b0870","unstructured":"World Health Organization, Global Recommendations on Physical Activity for Health 65 years and above, World Health Organization, 2011."},{"key":"10.1016\/j.intimp.2020.106434_b0875","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.irn.2019.06.003","article-title":"Exercise and Parkinson\u2019s disease","volume":"147","author":"Xu","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.intimp.2020.106434_b0880","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2017.12.004","article-title":"Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice","volume":"1680","author":"Yamawaki","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2020.106434_b0885","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1124\/mol.117.109512","article-title":"Activation of AMPK\/mTORC1-mediated autophagy by metformin reverses Clk1 deficiency-sensitized dopaminergic neuronal death","volume":"92","author":"Yan","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106434_b0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2017.00441","article-title":"Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2020.106434_b0895","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpba.2017.02.008","article-title":"Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC\/MS-based metabolomics","volume":"138","author":"Yu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.intimp.2020.106434_b0900","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12640-014-9467-y","article-title":"Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson\u2019s Disease","volume":"26","author":"Zaminelli","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.intimp.2020.106434_b0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116600","article-title":"Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson\u2019s disease in mice","volume":"232","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2020.106434_b0910","doi-asserted-by":"crossref","first-page":"107687","DOI":"10.1016\/j.neuropharm.2019.107687","article-title":"Blockade of calcium-permeable AMPA receptors in the lateral habenula produces increased antidepressant-like effects in unilateral 6-hydroxydopamine-lesioned rats compared to sham-lesioned rats","volume":"157","author":"Zhang","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106434_b0915","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroscience.2015.10.016","article-title":"Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson\u2019s disease rat model","volume":"311","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2020.106434_b0920","doi-asserted-by":"crossref","first-page":"e8434","DOI":"10.1590\/1414-431x20198434","article-title":"Baicalin ameliorates chronic mild stress-induced depression-like behaviors in mice and attenuates inflammatory cytokines and oxidative stress","volume":"52","author":"Zhong","year":"2019","journal-title":"Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. medicas e Biol."},{"key":"10.1016\/j.intimp.2020.106434_b0925","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of \u03b2-arrestin2 and NLRP3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2020.106434_b0930","first-page":"716859","article-title":"The involvement of neuroinflammation and Kynurenine pathway in Parkinson\u2019s disease","volume":"2011","author":"Zinger","year":"2011","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.intimp.2020.106434_b0935","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatment of psychosis in Parkinsons disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J. Psychopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920302083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920302083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:25:33Z","timestamp":1761585933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920302083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":187,"alternative-id":["S1567576920302083"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106434","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobiological findings underlying depressive behavior in Parkinson\u2019s disease: A review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106434"}}